IP Library Granted Patent US 7,048,308
Granted Patent B2
US 7,048,308 · App. 10/407,485 · Granted May 23, 2006

Excisable pharmaceutical label

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,048,308
App. No.
10/407,485
Granted
May 23, 2006
Kind
B2
Abstract

A pharmaceutical script includes a face sheet laminated to a liner by an adhesive therebetween. The face sheet includes a removable label defined by a perimeter diecut. The label includes an excisable tab spaced inboard from a surrounding rim. The tab includes a slit along one edge thereof. And, the label and tab are removable together from the liner to expose adhesive on the label rim, without adhesive being exposed on the tab.

Claims (62)

1. A pharmaceutical script comprising:

a face sheet including a removable label defined by a perimeter diecut;

said label including an integral excisable tab spaced inboard from a surrounding rim, and said tab includes a slit along one edge thereof;

said label tab being integrally formed with said label rim in a substantially imperforate configuration therewith for permitting tearing of said label tab from said label rim to excise said tab from said rim;

a liner laminated to said face sheet by an adhesive forming a removable bond between said label rim and said liner; and

said label and tab are removable together from said liner to expose adhesive on said label rim, without adhesive being exposed on said tab, and said exposed adhesive on said rim borders said excisable tab without exposed adhesive.

2. A method of using said script according to claim 1 comprising:

printing confidential information on said label tab;

removing said label and printed tab from said liner;

adhering said label and printed tab to a pharmaceutical container to expose to view said confidential information; and

excising said printed tab from said label and container commencing at said slit to remove said confidential information from said container.

3. A script according to claim 1 wherein said liner includes a diecut spaced inboard from a perimeter thereof to define a liner tab corresponding substantially in size and configuration with said label tab, and a liner rim corresponding with said label rim.

4. A script according to claim 3 wherein said tab slit as spaced outboard from said liner tab.

5. A script according to claim 3 wherein said tab slit is coextensive with said liner diecut.

6. A script according to claim 3 wherein:

said liner rim includes a coating of a release agent for forming a removable bond with said adhesive on said label rim; and

said liner tab is devoid of said release agent opposite said label tab for forming a permanent bond with said label tab by said adhesive therebetween.

7. A script according to claim 3 wherein said liner rim and tab include a coating of a release agent for forming a removable bond with both said label rim and tab at said adhesive therebetween.

8. A script according to claim 3 wherein said face sheet includes a plurality of removable labels laminated in common to said liner by said adhesive, with a single label having said excisable tab.

9. A script according to claim 8 wherein said face sheet further comprises an integral form sheet extending from said labels and liner.

10. A pharmaceutical script comprising:

a face sheet including a removable label defined by a perimeter diecut;

said label including an integral excisable tab spaced inboard from a surrounding rim, and said tab includes a slit along one edge thereof;

an imperforate liner laminated to said face sheet by an adhesive forming a removable bond between said label rim and said liner, and said label tab is substantially devoid of said adhesive; and

said label and tab are removable together from said liner to expose adhesive on said label rim, without adhesive being exposed on said tab.

11. A script according to claim 10 wherein said label tab is devoid of said adhesive inboard of said slit.

12. A method of using said script according to claim 3 comprising:

printing confidential information on said label tab;

removing said label and printed tab from said liner;

adhering said label and printed tab to a pharmaceutical container to expose to view said confidential information; and

excising said printed tab from said label and container commencing at said slit to remove said confidential information from said container.

13. A method according to claim 12 wherein:

said tab slit is spaced outboard from said liner tab; and

said label tab is torn from said label rim around the perimeter of said liner tab, and said liner tab is cleanly separated from said liner rim along said liner diecut.

14. A pharmaceutical script comprising:

a unitary face sheet having a plurality of removable labels laminated to a common release liner by an adhesive therebetween, and further including a form sheet extending below said labels and liner;

a main one of said labels including a central label tab spaced inboard from a surrounding label rim, and said label tab includes a slit along one edge thereof;

said liner includes a diecut spaced inboard from a perimeter thereof to define a liner tab corresponding with said label tab, and a liner rim corresponding with said label rim; and

wherein said liner rim and tab include a coating of a release agent for forming a removable bond with both said label rim and tab at said adhesive therebetween.

15. A method of using said script according to claim 14 comprising:

printing confidential information on said label tab;

removing said main label and printed tab from said liner;

adhering said main label and printed tab to a pharmaceutical container to expose to view said confidential information; and excising said printed tab from said main label and container commencing at said slit to remove said confidential information from said container.

16. A pharmaceutical script comprising:

a unitary face sheet having a plurality of removable labels laminated to a common release liner by an adhesive therebetween, and further including a form sheet extending below said labels and liner;

a main one of said labels including a central label tab spaced inboard from a surrounding label rim, and said label tab includes a slit along one edge thereof;

said liner includes a diecut spaced inboard from a perimeter thereof to define a liner tab corresponding with said label tab, and a liner rim corresponding with said label rim;

said liner rim includes a coating of a release agent for forming a removable bond with said adhesive on said label rim; and

said liner tab is devoid of said release agent opposite said label tab for forming a permanent bond with said label tab by said adhesive therebetween.

17. A pharmaceutical script comprising:

a unitary face sheet having a plurality of removable labels laminated to a common release liner by an adhesive therebetween, and further including a form sheet extending below said labels and liner;

a main one of said labels including a central label tab spaced inboard from a surrounding label rim, and said label tab includes a slit along one edge thereof;

said liner includes a diecut spaced inboard from a perimeter thereof to define a liner tab corresponding with said label tab, and a liner rim corresponding with said label rim;

said liner rim includes a coating of a release agent for forming a removable bond with said adhesive on said label rim;

said liner tab is devoid of said release agent opposite said label tab for forming a permanent bond with said label tab by said adhesive therebetween; and

wherein said tab slit is spaced outboard from said liner tab.

18. A method of using said script according to claim 17 comprising:

printing confidential information on said label tab;

removing said main label and printed tab from said liner;

adhering said main label and printed tab to a pharmaceutical container to expose to view said confidential information; and

excising said printed tab from said main label and container commencing at said slit to remove said confidential information from said container.

19. A method according to claim 18 wherein said label tab is torn from said label rim around the perimeter of said liner tab, and said liner tab is cleanly separated from said liner rim along said liner diecut.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Aug 23, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ICONEX LLC; MAX INTERNATIONAL CONVERTERS INC.; MAXSTICK PRODUCTS LTD.
Reel/Frame 068762/0334 →
RELEASE OF SECURITY INTEREST Recorded Jul 6, 2023
From: CERBERUS BUSINESS FINANCE AGENCY, LLC
To: ICONEX LLC
Reel/Frame 064219/0143 →
SECURITY INTEREST Recorded Jun 30, 2023
From: ICONEX LLC; MAX INTERNATIONAL CONVERTERS INC.; MAXSTICK PRODUCTS LTD.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 064179/0848 →
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT Recorded Apr 19, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ICONEX LLC
Reel/Frame 048949/0001 →
NOTICE OF SECURITY INTEREST - PATENTS Recorded Apr 16, 2019
From: ICONEX LLC
To: CERBERUS BUSINESS FINANCE AGENCY, LLC, AS COLLATERAL AGENT
Reel/Frame 048920/0223 →
SECURITY INTEREST Recorded Nov 20, 2016
From: ICONEX LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 040652/0524 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME: 032034/0010 Recorded Nov 3, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ICONEX LLC (AS SUCCESSOR IN INTEREST TO NCR CORPORATION)
Reel/Frame 040552/0324 →
RELEASE OF SECURITY INTEREST AT REEL/FRAME: 038646/0001 Recorded Nov 3, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ICONEX LLC (AS SUCCESSOR IN INTEREST TO NCR CORPORATION AND NCR INTERNATIONAL, INC.)
Reel/Frame 040554/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: NCR CORPORATION
To: ICONEX, LLC
Reel/Frame 038952/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2016
From: NCR CORPORATION
To: ICONEX LLC
Reel/Frame 038914/0234 →
SECURITY AGREEMENT Recorded Apr 18, 2016
From: NCR CORPORATION; NCR INTERNATIONAL, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 038646/0001 →
SECURITY AGREEMENT Recorded Jan 15, 2014
From: NCR CORPORATION; NCR INTERNATIONAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 032034/0010 →